Novo Nordisk's weight-loss challenge in 5 charts
Digest more
The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...
The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...
Eli Lilly is pursuing its own oral version of its obesity drug Zepbound. The Indiana-based company operates two new campuses ...
Danish pharmaceutical multinational Novo Nordisk is expanding its presence in inherited blood disorder treatments ...
European shares briefly hit a record high on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo ...
Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...
Regulators approved the first-ever GLP-1 pill for treating obesity from Novo Nordisk. Alphabet will acquire data center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback